MetaBloQ is a privately held biotechnology company based in Melbourne, Australia. The company is focused on the discovery and development of new drugs to treat difficult-to-treat cancers such as triple-negative breast cancer, prostate cancer and melanoma. Our unique approach targets metabolic processes specific to cancer cells so that our drugs will have minimal toxicity to normal healthy tissues.

Back to List